Saturday, January 20, 2024 10:22:12 PM
Recent ELUT News
- Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1 • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 01:15:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:24:44 PM
- Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024 • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 09:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:30:21 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/25/2024 09:56:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 10:00:12 PM
- Elutia Regains Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 01/10/2024 09:05:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:17:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:12:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:30:15 PM
- Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance • GlobeNewswire Inc. • 12/18/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:04:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/05/2023 09:54:18 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/05/2023 05:15:20 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/20/2023 09:53:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:26:13 PM
- Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:19:24 PM
- Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million • GlobeNewswire Inc. • 11/09/2023 01:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM